Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
Memorial Sloan Kettering Cancer Center.
J Natl Compr Canc Netw. 2020 Feb;18(2):120-131. doi: 10.6004/jnccn.2020.0007.
The NCCN Guidelines for Uveal Melanoma include recommendations for staging, treatment, and follow-up of patients diagnosed with uveal melanoma of the choroid or ciliary body. In addition, because distinguishing between uveal melanoma and benign uveal nevi is in some cases difficult, these guidelines also contain recommendations for workup of patients with suspicious pigmented uveal lesions, to clarify the tests needed to distinguish between those who should have further workup and treatment for uveal melanoma versus those with uncertain diagnosis and low risk who should to be followed and later reevaluated. These NCCN Guidelines Insights describe recommendations for treatment of newly diagnosed nonmetastatic uveal melanoma in patients who have already undergone a complete workup.
NCCN 葡萄膜黑色素瘤指南包括对脉络膜或睫状体葡萄膜黑色素瘤患者的分期、治疗和随访的建议。此外，由于在某些情况下难以区分葡萄膜黑色素瘤和良性葡萄膜痣，这些指南还包含了对可疑色素性葡萄膜病变患者的检查建议，以明确需要进行哪些检查来区分那些需要进一步检查和治疗葡萄膜黑色素瘤的患者与那些诊断不确定且风险较低的患者，后者应进行随访和后续重新评估。这些 NCCN 指南洞察描述了对已经完成全面检查的新诊断为非转移性葡萄膜黑色素瘤患者的治疗建议。
